DTIL

Precision BioSciences Inc (DTIL)

US
$ 5.180.58%

Price Chart

Key Statistics

Market Cap
$ 47.24M
P/E Ratio
0.00
Revenue (TTM)
$ 51.14M
Volume
73.84K
52W High
$ 11.09
52W Low
$ 3.61
Dividend Yield
0.00%
Beta
1.47

Technicals

50-Day MA
4.9687
200-Day MA
6.0072
52 Week High
11.09
52 Week Low
3.61

About DTIL

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States.

Employees
107
Headquarters
Durham, NC
CEO
Mr. Michael Amoroso

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96